EcoDrugPlus

Adenosine A2b Receptor

Ensembl ID : ENSSTOG00000004237
Gene Symbol: ADORA2B
3 Cross references
200 Possible Orthologues:

Adenosine A3 Receptor

Ensembl ID : ENSSTOG00000025181
Gene Symbol: ADORA3
2 Cross references
89 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSSTOG00000026859
Gene Symbol: LOC101972772
1 Cross references
215 Possible Orthologues:

Adenosine Deaminase-Like

Ensembl ID : ENSSTOG00000022041
Gene Symbol: LOC101972479
1 Cross references
215 Possible Orthologues:

Adrenoceptor Alpha 1a

Ensembl ID : ENSSTOG00000019888
Gene Symbol: ADRA1A
4 Cross references
201 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSSTOG00000026778
Gene Symbol: ADRA1B
4 Cross references
263 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSSTOG00000027171
Gene Symbol: ADRA1D
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSSTOG00000032191
Gene Symbol: ADRA2A
3 Cross references
230 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSSTOG00000026091
Gene Symbol: ADRA2B
3 Cross references
219 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSSTOG00000019369
Gene Symbol: ADRB1
2 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSSTOG00000010102
Gene Symbol: ADRB2
3 Cross references
263 Possible Orthologues:

Adrenoceptor Beta 3

Ensembl ID : ENSSTOG00000024747
Gene Symbol: ADRB3
3 Cross references
215 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).